Clinical Minds
By Medidata
Clinical MindsJul 29, 2020
How the FDA is focused on improving clinical trial access, enrollment, and enhancing public trust and education
The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity.
Related links
https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity
How to better bridge the gaps in Latinx patients clinical trial participation with Dr. Fabian Sandoval
The simplest thing to do is to find out what kind of patients you have. Find out what cultures they are. Learn about the culture. Learn to connect. Be a human. Don't just be a robot that does science. Don't speak above someone's level. Speak to them. Put yourself in that patient's shoes, and speak to them kindly,” says Dr. Fabian Sandoval, CEO and Research Director of the Emerson Clinical Research Institute in Washington, DC, and Emmy winner and host of the weekly medical TV show "Tu Salud, Tu Familia
The importance of community building, patient trust, and improving access to cancer clinical trials with Dana Dornsife
Currently our black and brown communities are really grossly underrepresented in cancer clinical trials, and we need to fix that. Historical barriers around egregious medical behaviors that have taken place in the past, cultural barriers, language barriers, and finally socioeconomic barriers impact the outcome of someone’s cancer journey,” says Dana Dornsife, founder and CEO at Lazarex Cancer Foundation, a nationwide non-profit org she founded in 2006.
A brief history of inequity in the practice of medicine & medical experimentation with Harriet A. Washington
A lot has to do with the ability to admit the painful truth about American racism in healthcare and then to make the equally painful changes that it requires,” says Harriet A. Washington, medical ethicist, American writer, and the author of Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present and Carte Blanche
Introducing Season 2: Diversity in Clinical Trials
Introducing Season 2 of Clinical Minds! An entire season dedicated to why diversity in clinical trials is so important and what’s being done to improve participation among underrepresented populations.
To kick things off, host Paul Oestreicher chats with Jackie Kent, evp and chief customer officer at Medidata, a Dassault Systèmes
What is a patient equation?
Glen de Vries, co-founder and co CEO of Medidata and author of the upcoming book, The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond on how to bring together everything learned about COVID-19 to find treatments and vaccines and what can be done to make sure something like this doesn't happen again.
What if a treatment already exists?
Dr. David Fajgenbaum, physician, scientist and author of the bestselling memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action, on his approach to drug repurposing, how he and a team of volunteers have been applying this approach to Covid-19, and why this gives hope for all diseases with unmet need.
What is the data telling us?
Fareed Melhem, head of Acorn AI Labs, on what data trends reveal about Covid-19's global impact on clinical research, and how data science is being used to overcome challenges created by the pandemic.
What do virtual clinical trials look like?
Anthony Costello, senior vice president of mobile health at Medidata, on what clinical trials look like when people are unable or unwilling to leave home, what this means for the race for a vaccine, and how mobile health technology is paving the way.
How do we keep clinical trial patients safe in a pandemic?
How drugs go from a lab, to testing in humans, to your local pharmacy. Here's what’s happening in the world of clinical research today, the technology and ideas that are transforming it, and why this matters for patients. Which is all of us. Presented by Medidata.
When will we get the vaccine?
Clinical trials 101. Alicia Staley, director of patient engagement at Medidata, on why it takes so long to develop drugs and vaccines, what clinical trials are, and how clinical trials can do better for patients.